The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...

a Based on the 2003 Red Book average wholesale price of $538.42 per 250,000-IU vial and $0.17 and $0.05 per syringe and cap, respectively.

Heart disease, including heart attacks and strokes, remains the leading cause of death in the United States. Despite efforts ...

They found that T-cells can be used to fight off another type of cell called the uPAR (urokinase plasminogen activator ...

MNPR-101 is Monopar’s proprietary first-in-class humanized monoclonal antibody that targets cancers expressing the urokinase ...

Discover all the brand names or Trade names of generic drug called Urokinase. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

(RTTNews) - Monopar Therapeutics Inc. (MNPR), Thursday announced positive early data from its ongoing open-label MNPR-101-Zr Phase 1 trial, confirming the compound's tumor-targeting ability in humans.

A randomised double blind placebo controlled trial of intrapleural urokinase was performed in children with parapneumonic empyema. Methods: Sixty children (median age 3.3 years) were recruited from 10 ...

Recommendations for management options include initially the use of anticoagulation. For patients with a poor prognosis, local thrombolysis with urokinase or recombinant tissue plasminogen activator ...